American Recovery and Reinvestment Act EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) INFRASTRUCTURE AND INTEROPERABILITY SUPPORT FOR PUBLIC HEALTH LABORATORIES
The purpose of the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) cooperative agreement is to assist state public health agencies in improving surveillance for, and response to, infectious diseases by (1) strengthening epidemiologic capacity; (2) enhancing laboratory capacity and
practice; (3) improving information systems; and (4) developing and implementing prevention and control strategies.
The focus of the activities is on naturally occurring infectious diseases and drug-resistant infections.
ELC aims to enhance the ability of public health agencies to identify and monitor the occurrence of known infectious diseases of public health importance; detect new and emerging infectious disease threats, identify and respond to disease outbreaks; and use public health data for priority setting, policy development, and for prevention and control.
Specifically within the Health Information Systems/National Electronic Disease Surveillance System (NEDSS) component of ELC, a key goal is to develop direct electronic data exchanges between sources of data (such as health care providers or laboratories i.e., clinical care) and public health agencies.The purpose of this funding from the ARRAHITECH Act is to support states through the ELC program to enhance and advance infrastructure and interoperability support for public health laboratories to satisfy Stage 1 Meaningful Use criteria as set out in the Centers for Medicare and Medicaid Services Meaningful Use Notice of Proposed Rule Making (published on January 13, 2010 in the Federal Register at edocket.access.gpo.gov/2010E9-3121 7. htm) for reporting to public health agencies using, when applicable, the HHS Standards & Certification Interim Final Rule:
Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (available at edocket.access.gpo.gov/2010E9-3121 6. htm).
These include the capability to provide electronic submission of reportable (as required by state or local law) lab results to public health agencies and actual submission where it can be received.
See Appendix B for additional information on the Interim Final Rule and the Meaningful Use Notice of Proposed Rule Making.
The focus of the activities is on naturally occurring infectious diseases and drug-resistant infections.
ELC aims to enhance the ability of public health agencies to identify and monitor the occurrence of known infectious diseases of public health importance; detect new and emerging infectious disease threats, identify and respond to disease outbreaks; and use public health data for priority setting, policy development, and for prevention and control.
Specifically within the Health Information Systems/National Electronic Disease Surveillance System (NEDSS) component of ELC, a key goal is to develop direct electronic data exchanges between sources of data (such as health care providers or laboratories i.e., clinical care) and public health agencies.The purpose of this funding from the ARRAHITECH Act is to support states through the ELC program to enhance and advance infrastructure and interoperability support for public health laboratories to satisfy Stage 1 Meaningful Use criteria as set out in the Centers for Medicare and Medicaid Services Meaningful Use Notice of Proposed Rule Making (published on January 13, 2010 in the Federal Register at edocket.access.gpo.gov/2010E9-3121 7. htm) for reporting to public health agencies using, when applicable, the HHS Standards & Certification Interim Final Rule:
Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (available at edocket.access.gpo.gov/2010E9-3121 6. htm).
These include the capability to provide electronic submission of reportable (as required by state or local law) lab results to public health agencies and actual submission where it can be received.
See Appendix B for additional information on the Interim Final Rule and the Meaningful Use Notice of Proposed Rule Making.
Related Programs
ARRAHealth Information Technology and Public Health
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Estimated Funding: $5,000,000
Office: Centers for Disease Control and Prevention
Estimated Funding: $5,000,000
Obtain Full Opportunity Text:
Please find the link to the full announcement at the top of this page.
Additional Information of Eligibility:
Eligibility for these awards is limited to current grantees under the ELC cooperative agreement program which include: -50 States -District of Columbia -Commonwealth of Puerto Rico -Republic of Palau -Cities of Chicago, IL; Houston, TX; Los Angeles, CA; New York, NY; Philadelphia, PA These 58 eligible applicants are currently funded under the following ELC Funding Opportunity Numbers: CI04-040:
Full Opportunity Web Address:
Contact:
CDCProcurement and Grants Office (PGO)Technical Information Manageement Section (TIMS)Phone 770-488-2700
Agency Email Description:
Technical Information Management Section (TIMS)
Agency Email:
PGOTIM@cdc.gov
Date Posted:
2010-05-06
Application Due Date:
2010-06-08
Archive Date:
2010-07-08
Social Entrepreneurship
Spotlight
Keeping Half the Profits Beats Non-profits for Social Impact
Melbourne social enterprise Who Gives A Crap sold nearly 3 million rolls of toilet paper in 2014/15 and gave half the proceeds to WaterAid Australia, but co-founder Simon Griffiths says the donation would have been less had the startup adopted a non-profit model when it launched two years ago.
Learn How to Identify and Avoid Grant Scams
